Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

NCT00993343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

215

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host Disease
Survival

Interventions

DRUG: Sirolimus/tacrolimus
DRUG: cyclosporine/methotrexate

Sponsor

Karolinska Institutet